<DOC>
	<DOCNO>NCT00124787</DOCNO>
	<brief_summary>Dimenhydrinate , over-the-counter , widely use drug Canada , ethanolamine-derivative anti-histamine . It limit stimulation vomit center vestibular system , rich histamine receptor . Multiple study show effectiveness treatment post-operative nausea vomit child . It also use treatment vertigo child . Furthermore , potential much cost-effective ondansetron , average cost $ 0.90 US per dose . Its principal side effect drowsiness , dizziness anticholinergic symptom . Restlessness insomnia also describe child . To date , publish data efficacy dimenhydrinate control emesis child acute gastroenteritis . RESEARCH QUESTION Do child treat oral dimenhydrinate acute gastro-enteritis experience less vomit episode child treat placebo ?</brief_summary>
	<brief_title>A Trial Comparing Effect Oral Dimenhydrinate Versus Placebo Children With Gastroenteritis</brief_title>
	<detailed_description>STRUCTURED RESEARCH ABSTRACT Background : The use antiemetic drug treat nausea vomit episode acute gastroenteritis child remain controversial . To date , limited number clinical trial study subject matter health authority ' recommendation base expert opinion . Surveys show despite lack evidence , physicians quite frequently prescribe drug . Dimenhydrinate , histamine receptor blocker , proven safe effective control post-operative nausea vomit child . To knowledge , clinical trial conduct study efficacy child acute gastroenteritis . Objective : To evaluate efficacy safety oral dimenhydrinate treatment vomit due acute gastroenteritis child . Design : Randomized , double-blind , placebo control clinical trial . Setting : Emergency Department ( ED ) urban pediatric university-affiliated center . Study population : Children 1 12 year age present ED least 5 episode vomit previous 12 hour diagnose acute gastroenteritis attend physician . Interventions : Study participant randomly allocate receive 8 dos dimenhydrinate placebo every six hour ( 1mg/kg/dose , max dose 50mg/dose ) Primary outcome measure : Number good outcome , define 1 episode less vomit 24 hour first dose drug administration . Secondary outcome measure : Need intravenous fluid administration , number duration vomit diarrhea , side effect , revisit rate parental absenteeism work compare two group Sample size statistic : Based previously report data , researcher estimate approximately 70 % patient free emesis initial 24 hour post medication first dose . The researcher would like obtain good outcome 85 % active medication . With alpha error 0.05 power 90 % , approximately 90 patient per group need . Patients ' characteristic outcome compare use Mann Whitney U test Chi-square test categorical variable Student 's T test continuous variable . Survival curve also analyze .</detailed_description>
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Dimenhydrinate</mesh_term>
	<criteria>Children age 1 12 year old 5 episode vomit 12 hour precede diagnosis acute gastroenteritis ED attend physician Preexisting chronic medical condition gastrointestinal disease , malignancy , metabolic , cardiac , endocrine , immunologic neurologic disorder Suspected secondary diagnosis surgical abdomen gynecologic condition , urinary tract infection , migraine meningitis Use antiemetic therapy within 48 hour prior ED visit Use medication acetaminophen ibuprofen previous 48 hour History allergy adverse reaction dimenhydrinate Severe dehydration require immediate intravenous fluid therapy Hematemesis hematochezia</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>